Molecular mechanisms linking BRAF mutations and the expression of immunoregulatory molecules, galectin-1 and PD-L1 in melanoma
2014/15/N/NZ5/03662
Keywords
Descriptors
- NZ5_3: Patogeneza chorób człowieka
- NZ5_7: Leczenie chorób człowieka
- NZ5_5: Diagnostyka chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Instytut Hematologii i Transfuzjologii
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Maja Magdalena Wasylecka-Juszczyńska
Number of co-investigators in the project: 2
Call
PRELUDIUM 8 – announced on 2014-09-15
- Amount awarded
- 100 000 PLN
- Project start date
- 2015-10-01
- Project end date
- 2017-12-31
- Project duration
- 27 months (the same as in the proposal)
- Project status
- Project settled
Information in the final report
Publication in academic press/journals (1)
-
BRAF inhibition curtails IFN-gamma-inducible PD-L1 expression and upregulates the immunoregulatory protein galectin-1 in melanoma cells
- Authors:
- Patryk Gorniak, Maja Wasylecka-Juszczynska, Iwona Ługowska, Piotr Rutkowski, Anna Polak, Maciej Szydłowski, Przemysław Juszczynski
- Academic press:
- Molecular Oncology (year: 2020, volume: Early view, pages: 46038), Publisher: Wiley
- Status:
- Published
- DOI:
- 10.1002/1878-0261.12695 – link to the publication
Articles in post-conference publications (1)
-
BRAF V600E mutation in melanoma sustains IFN-gamma inducible PD-L1 expression by coactivating STAT1 and increasing protein translation.
- Authors:
- M. Wasylecka-Juszczyńska, P. Górniak, M. Szydłowski, A. Polak, P. Juszczyński
- Conference:
- 2018 ESMO Annual Meeting (year: 2018, pages: Annals of Oncology, 2018, vol. 29 Suppl 8, viii463), Publisher: Elsevier
- Date:
- conference 19-23 October 2018 Munich, Germany.
- Status:
- Published